Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Nov 22, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TPR | TAPESTRY INC | NYSE | Luxury Goods | A | $20.91B | $102.18 | -2.14% | $598.20M | 75.13x | 14.93 | United States | 38 |
| JBL | JABIL INC | NYSE | Electronic Components | A | $20.57B | $192.49 | -3.80% | $1.71B | 32.08x | 11.25 | United States | 47 |
| PTC | PTC INC | NASDAQ | Software - Application | A | $20.42B | $170.43 | -0.88% | $885.58M | 40.01x | 0.77 | United States | 46 |
| THC | TENET HEALTHCARE CORP | NYSE | Medical Care Facilities | A | $16.41B | $186.68 | -3.90% | $3.48B | 12.60x | 5.16 | United States | 34 |
| NVT | NVENT ELECTRIC PLC | NYSE | Electrical Equipment & Parts | A | $16.38B | $101.52 | -3.99% | $1.08B | 27.66x | 0.86 | United Kingdom | 39 |
| NBIX | NEUROCRINE BIOSCIENCES INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $13.86B | $138.98 | 0.67% | $679.20M | 32.25x | 0.42 | United States | 52 |
| VTRS | VIATRIS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $11.74B | $10.19 | -2.58% | -$598.90M | -3.30x | 1.49 | United States | 24 |
| PRIM | PRIMORIS SERVICES CORP | NYSE | Engineering & Construction | A | $6.31B | $116.73 | -4.72% | $513.21M | 22.75x | 1.86 | United States | 54 |
| MOG.A | MOOG INC | NYSE | Aerospace & Defense | A | $6.29B | $198.57 | 0.58% | $436.71M | 29.82x | 1.26 | United States | 31 |
| SGHC | SUPER GROUP (SGHC) LTD | NYSE | Gambling | A | $5.86B | $11.59 | -5.93% | N/A | 23.27x | 0.60 | Guernsey | 35 |
| GTES | GATES INDUSTRIAL CORP PLC | NYSE | Specialty Industrial Machinery | A | $5.47B | $21.18 | -1.67% | $672.10M | 23.02x | 1.02 | United States | 37 |
| MIRM | MIRUM PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $3.55B | $69.16 | -1.81% | -$592.00k | -81.36x | 1.69 | United States | 26 |
| FOLD | AMICUS THERAPEUTICS INC | NASDAQ | Biotechnology | A | $2.92B | $9.45 | -2.88% | $59.28M | -236.25x | 2.77 | United States | 23 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $2.57B | $44.79 | -1.99% | $64.66M | -135.73x | 0.35 | United States | 28 |
| SPNT | SIRIUSPOINT LTD | NYSE | Insurance - Reinsurance | A | $2.31B | $19.75 | -0.50% | $339.10M | 11.90x | 4.64 | Bermuda | 28 |
| HCI | HCI GROUP INC | NYSE | Insurance - Property & Casualty | A | $2.21B | $170.39 | -1.62% | $301.16M | 9.87x | 1.82 | United States | 50 |
| DBD | DIEBOLD NIXDORF INC | NYSE | Software - Application | A | $2.15B | $60.01 | -3.46% | $303.10M | 43.17x | 2.36 | United States | 37 |
| IHS | IHS HOLDING LTD | NYSE | Telecom Services | A | $2.11B | $6.30 | -0.47% | N/A | 4.50x | -34.21 | United Kingdom | 30 |
| PGY | PAGAYA TECHNOLOGIES LTD | NASDAQ | Software - Infrastructure | A | $1.71B | $20.79 | -5.63% | -$155.79M | -7.59x | 2.03 | Israel | 21 |
| ATRO | ASTRONICS CORP | NASDAQ | Aerospace & Defense | A | $1.68B | $47.13 | -4.52% | $41.60M | -589.13x | 5.26 | United States | 19 |
| BLBD | BLUE BIRD CORP | NASDAQ | Auto Manufacturers | A | $1.61B | $50.78 | 0.05% | $175.74M | 13.99x | 1.59 | United States | 46 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $1.48B | $7.03 | 1.44% | $83.87M | -140.60x | -2.15 | United States | 17 |
| ANAB | ANAPTYSBIO INC | NASDAQ | Biotechnology | A | $1.04B | $37.66 | 1.76% | -$82.14M | -13.74x | -13.00 | United States | 15 |
| CRTO | CRITEO SA | NASDAQ | Advertising Agencies | A | $1.04B | $19.78 | -0.50% | $219.28M | 6.34x | 0.79 | France | 51 |
| NRDS | NERDWALLET INC | NASDAQ | Internet Content & Information | A | $967.09M | $13.30 | -2.64% | $98.00M | 13.71x | 0.23 | United States | 47 |
| TBPH | THERAVANCE BIOPHARMA INC | NASDAQ | Biotechnology | A | $907.04M | $17.90 | 0.96% | $55.37M | 30.86x | 0.79 | Cayman Islands | 37 |
| ORGO | ORGANOGENESIS HOLDINGS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $649.79M | $5.12 | -0.19% | $18.04M | -42.67x | 0.49 | United States | 23 |
| BWMN | BOWMAN CONSULTING GROUP LTD | NASDAQ | Engineering & Construction | A | $564.80M | $32.51 | -1.60% | $38.00M | 33.17x | 0.95 | United States | 53 |
| VREX | VAREX IMAGING CORP | NASDAQ | Medical Devices | A | $429.09M | $10.29 | 0.49% | -$1.00M | -6.05x | 1.31 | United States | 24 |
| AKBA | AKEBIA THERAPEUTICS INC | NASDAQ | Biotechnology | A | $408.66M | $1.54 | -3.14% | $25.70M | -19.25x | 7.76 | United States | 25 |
| ALLT | ALLOT LTD | NASDAQ | Software - Infrastructure | A | $359.69M | $8.67 | 1.52% | $5.78M | 216.75x | 0.57 | Israel | 40 |
| OPRX | OPTIMIZERX CORP | NASDAQ | Health Information Services | A | $253.14M | $13.58 | -4.77% | $11.65M | N/A | 0.39 | United States | 29 |
| EGHT | 8X8 INC | NASDAQ | Software - Application | A | $252.33M | $1.82 | -1.62% | $51.06M | -45.50x | 4.04 | United States | 16 |
| ELMD | ELECTROMED INC | NYSEMKT | Medical Devices | A | $209.35M | $25.10 | -0.44% | $12.05M | 25.88x | 0.20 | United States | 54 |
| INFU | INFUSYSTEM HOLDINGS INC | NYSEMKT | Medical Instruments & Supplies | A | $187.50M | $9.22 | -0.65% | $24.16M | 35.46x | 0.78 | United States | 45 |
| CXDO | CREXENDO INC | NASDAQ | Telecom Services | A | $179.16M | $5.83 | -3.32% | $7.94M | 38.87x | 0.24 | United States | 44 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.